These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21102648)

  • 1. Lorcaserin--not a new weapon in the battle with appetite.
    Halford JC
    Nat Rev Endocrinol; 2010 Dec; 6(12):663-4. PubMed ID: 21102648
    [No Abstract]   [Full Text] [Related]  

  • 2. Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.
    Scirica BM; Bohula EA; Dwyer JP; Qamar A; Inzucchi SE; McGuire DK; Keech AC; Smith SR; Murphy SA; Im K; Leiter LA; Gupta M; Patel T; Miao W; Perdomo C; Bonaca MP; Ruff CT; Sabatine MS; Wiviott SD;
    Circulation; 2019 Jan; 139(3):366-375. PubMed ID: 30586726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, placebo-controlled trial of lorcaserin for weight management.
    Smith SR; Weissman NJ; Anderson CM; Sanchez M; Chuang E; Stubbe S; Bays H; Shanahan WR;
    N Engl J Med; 2010 Jul; 363(3):245-56. PubMed ID: 20647200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lorcaserin: an investigational serotonin 2C agonist for weight loss.
    Hurren KM; Berlie HD
    Am J Health Syst Pharm; 2011 Nov; 68(21):2029-37. PubMed ID: 22011982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New medications for weight loss.
    Murfin M
    JAAPA; 2012 Dec; 25(12):59-60. PubMed ID: 23600006
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2010 Mar; 39(1):69-79. PubMed ID: 20202580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current pharmacotherapy for obesity.
    Srivastava G; Apovian CM
    Nat Rev Endocrinol; 2018 Jan; 14(1):12-24. PubMed ID: 29027993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT(2C) receptor agonists and the control of appetite.
    Halford JC; Harrold JA
    Handb Exp Pharmacol; 2012; (209):349-56. PubMed ID: 22249823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon?
    Prescrire Int; 2012 Sep; 21(130):209. PubMed ID: 23016252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy comparison of medications approved for chronic weight management.
    Kumar RB; Aronne LJ
    Obesity (Silver Spring); 2015 Apr; 23 Suppl 1():S4-7. PubMed ID: 25900871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorcaserin approval in the United States: paving the way?
    Pedersen SD; Astrup A
    Endocrinol Nutr; 2012 Nov; 59(9):521-2. PubMed ID: 22939712
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug management of obesity--efficacy versus safety.
    Astrup A
    N Engl J Med; 2010 Jul; 363(3):288-90. PubMed ID: 20647205
    [No Abstract]   [Full Text] [Related]  

  • 13. ACS chemical neuroscience molecule spotlight on Qnexa.
    Mercer SL
    ACS Chem Neurosci; 2011 Apr; 2(4):183-4. PubMed ID: 22778866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-obesity drugs.
    Proietto J
    Med J Aust; 1998 Apr; 168(8):409-12. PubMed ID: 9594954
    [No Abstract]   [Full Text] [Related]  

  • 15. Lorcaserin. In obesity: unacceptable risks.
    Prescrire Int; 2014 May; 23(149):117-20. PubMed ID: 24926508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Horizons in the Pharmacotherapy of Obesity.
    Arch JR
    Curr Obes Rep; 2015 Dec; 4(4):451-9. PubMed ID: 26346394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
    Toubro S
    Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
    [No Abstract]   [Full Text] [Related]  

  • 18. New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).
    Shyh G; Cheng-Lai A
    Cardiol Rev; 2014; 22(1):43-50. PubMed ID: 24304809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre, placebo-controlled trial of lorcaserin for weight management in Chinese population.
    Lu CW; Chang CJ; Yang YC; Lin WY; Huang KC
    Obes Res Clin Pract; 2018 Jul; 12(5):465-471. PubMed ID: 30033356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.